Literature DB >> 18242385

The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.

Elisabeth I Heath1, Michael W Kattan, Isaac J Powell, Wael Sakr, Timothy C Brand, Benjamin A Rybicki, Ian M Thompson, William J Aronson, Martha K Terris, Christopher J Kane, Joseph C Presti, Christopher L Amling, Stephen J Freedland.   

Abstract

OBJECTIVES: To test the accuracy of the 2001 Partin Tables in African American men who underwent radical prostatectomy at multiple centers throughout the United States.
METHODS: We compiled a large multiethnic cohort of men (n = 3748) treated with radical prostatectomy at multiple sites, including all of the sites of the Department of Veterans Affairs-based Shared Equal Access Regional Cancer Hospital (SEARCH) database (n = 1524), Wayne State University (n = 1305), the University of Texas Health Science Center (n = 522), and the Henry Ford Hospital (n = 397). We evaluated the accuracy of the 2001 Partin Tables using area under the receiver operator characteristic curve (AUC) separately among African American and white men.
RESULTS: African American men (n = 1188, 32%), despite being more likely to have clinical Stage T1c disease (56% versus 47%, chi-square P <0.001), had higher preoperative PSA values (9.1 versus 7.7 ng/mL, rank-sum P <0.001) and were more likely to have higher-grade disease on diagnostic biopsy (chi-square P = 0.005). Despite these differences in baseline clinical characteristics, the 2001 Partin Tables performed equally well in both racial groups. Specifically, there were no differences in the AUC for African American and white men for predicting organ-confined disease (AUC 0.73 versus 0.72; P = 0.56), extraprostatic extension (AUC 0.62 versus 0.62; P = 0.99), or seminal vesicle invasion (AUC 0.77 versus 0.79; P = 0.53).
CONCLUSIONS: These data lend further support to the idea that although baseline differences between the races existed that may underlie an overall more aggressive disease among African American men, for the individual patient, race is not valuable for prognostication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242385     DOI: 10.1016/j.urology.2007.08.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.

Authors:  Ying Huang; Sumit Isharwal; Alexander Haese; Felix K H Chun; Danil V Makarov; Ziding Feng; Misop Han; Elizabeth Humphreys; Jonathan I Epstein; Alan W Partin; Robert W Veltri
Journal:  BJU Int       Date:  2010-09-28       Impact factor: 5.588

2.  Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.

Authors:  D M Fanning; F Yue; J M Fitzpatrick; R W G Watson
Journal:  Ir J Med Sci       Date:  2009-07-14       Impact factor: 1.568

3.  The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Authors:  D M Moreira; J C Presti; W J Aronson; M K Terris; C J Kane; C L Amling; L L Sun; J W Moul; S J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-11-17       Impact factor: 5.554

4.  Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort.

Authors:  Jennifer Cullen; Stephen A Brassell; Yongmei Chen; Christopher Porter; James L'esperance; Timothy Brand; David G McLeod
Journal:  Prostate Cancer       Date:  2011-06-26

Review 5.  Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.

Authors:  James Farrell; Gyorgy Petrovics; David G McLeod; Shiv Srivastava
Journal:  Int J Mol Sci       Date:  2013-07-25       Impact factor: 5.923

6.  Prostate Cancer in Southern Africa: Does Africa Hold Untapped Potential to Add Value to the Current Understanding of a Common Disease?

Authors:  Vanessa M Hayes; M S Riana Bornman
Journal:  J Glob Oncol       Date:  2017-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.